Ginkgo Bioworks Holdings (DNA) Exchange Rate Effect (2021 - 2026)
Ginkgo Bioworks Holdings posted quarterly Exchange Rate Effect of -$129000.0 for Q1 2026, down 274.32% year-on-year from $74000.0 in Q1 2025, and up 15.13% on a QoQ basis from -$152000.0 in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 6 years of Exchange Rate Effect data on file, last reported at -$129000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 274.32% year-over-year to -$129000.0; the trailing twelve-month figure through Mar 2026 stood at -$2000.0 (up 96.0% YoY), and the FY2025 full-year result was $201000.0, up 171.53% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$129000.0, up from -$152000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2022 and bottomed at -$469000.0 in Q2 2023.
- The 5-year median for Exchange Rate Effect is -$35000.0 (2024), against an average of $6529.4.
- Peak annual rise in Exchange Rate Effect reached 10090.91% in 2022, while the deepest fall reached 987.5% in 2022.
- A 5-year view of Exchange Rate Effect shows it stood at $1.1 million in 2022, then plunged by 90.72% to $102000.0 in 2023, then tumbled by 171.57% to -$73000.0 in 2024, then plunged by 108.22% to -$152000.0 in 2025, then advanced by 15.13% to -$129000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$129000.0 (Q1 2026), -$152000.0 (Q4 2025), and $93000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | -129,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129,000.00 |
| Mar 31, 2026 | -129,000.00 |
| Dec 31, 2025 | -152,000.00 |
| Dec 31, 2025 | -152,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | -73,000.00 |
| Dec 31, 2024 | -73,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -157,000.00 |
| Mar 31, 2024 | -157,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Sep 30, 2023 | -195,000.00 |
| Sep 30, 2023 | -195,000.00 |
| Jun 30, 2023 | -469,000.00 |
| Jun 30, 2023 | -469,000.00 |
| Mar 31, 2023 | -26,000.00 |
| Mar 31, 2023 | -26,000.00 |
| Dec 31, 2022 | 1.10 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | -87,000.00 |
| Sep 30, 2022 | -87,000.00 |
| Jun 30, 2022 | -96,000.00 |
| Jun 30, 2022 | -96,000.00 |
| Mar 31, 2022 | -8,000.00 |
| Mar 31, 2022 | -8,000.00 |
| Dec 31, 2021 | -11,000.00 |
| Dec 31, 2021 | -11,000.00 |
| Sep 30, 2021 | -8,000.00 |
| Sep 30, 2021 | -8,000.00 |